UMIN-ICDS Clinical Trial
| Unique ID issued by UMIN | UMIN000060748 |
|---|---|
| Receipt number | R000069501 |
| Scientific Title | Characteristics of instrumental activities of daily living in older adults with subjective cognitive decline |
| Date of disclosure of the study information | 2026/02/26 |
| Last modified on | 2026/02/25 21:24:38 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A study examining daily life characteristics in adults aged 70 years and older with concerns about their memory
Acronym
MemoryLife70
Scientific Title
Characteristics of instrumental activities of daily living in older adults with subjective cognitive decline
Scientific Title:Acronym
SCD-IADL Study
Region
| Japan |
Condition
Condition
Subjective Cognitive Decline
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The purpose of this study is to investigate the association between subjective cognitive decline (SCD) and instrumental activities of daily living (IADL) in community-dwelling older adults.
As a secondary analysis, the characteristics of IADL according to the presence or absence of discrepancy between subjective cognitive assessment and objective cognitive function will be descriptively examined.
Basic objectives2
Others
Basic objectives -Others
This study is a cross-sectional observational study in community-dwelling older adults designed to examine the association between subjective cognitive decline and instrumental activities of daily living (IADL).
Trial characteristics_1
Exploratory
Trial characteristics_2
Explanatory
Developmental phase
Not applicable
Assessment
Primary outcomes
Total score of the Japanese version of the Frenchay Activities Index(SR-FAI),assessed once at baseline.
Key secondary outcomes
Score of the self-administered dementia checklist (used to assess/classify SCD)
Subscale scores of the Japanese SR-FAI
Mirevo score (objective cognitive function assessment)
GDS-15 score (depressive symptoms)
Demographics (age, sex, years of education, etc.)
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 70 | years-old | <= |
Age-upper limit
| 120 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Community-dwelling adults aged 70 years or older
Individuals who are able to walk independently or are independent in mobility
Individuals who can understand the study and provide informed consent
Key exclusion criteria
Individuals who meet the contraindications or exclusion criteria for Mirevo, including those with severe ophthalmologic diseases that prevent eye tracking or visual recognition of the projected screen.
Specifically:
Individuals with blindness, low vision, glaucoma, retinitis pigmentosa, diabetic retinopathy, age-related macular degeneration, visual field defects, central scotoma, visual field loss, color vision disorders, or light perception disorders.
Individuals with active neurological or psychiatric diseases, including multiple sclerosis, amyotrophic lateral sclerosis, Guillain-Barre syndrome, encephalitis or meningitis, schizophrenia, severe depression, bipolar disorder, or severe personality disorders.
Individuals diagnosed with Alzheimer's disease, vascular dementia, dementia with Lewy bodies, frontotemporal dementia, or mild cognitive impairment (MCI) by a medical institution.
Target sample size
94
Research contact person
Name of lead principal investigator
| 1st name | Kazue |
| Middle name | |
| Last name | Noda |
Organization
Graduate School of Health Sciences, Kobe University
Division name
Department of Rehabilitation Sciences
Zip code
654-0142
Address
7-10-2 Tomogaoka,Suma-ku, Kobe , Japan
TEL
0787964572
noda@kobe-u.ac.jp
Public contact
Name of contact person
| 1st name | Kaori |
| Middle name | |
| Last name | Yoshikawa |
Organization
Graduate School of Health Sciences, Kobe University
Division name
Department of Rehabilitation Sciences
Zip code
654-0142
Address
7-10-2 Tomogaoka,Suma-ku, Kobe , Japan
TEL
09092679859
Homepage URL
251K212k@stu.kobe-u.ac.jp
Sponsor or person
Institute
Kobe University
Institute
Department
Personal name
Kaori Yoshikawa
Funding Source
Organization
Kobe University
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Ethics Committee of the Graduate School of Health Sciences,Kobe University
Address
7-10-2 Tomogaoka,Suma-ku, Kobe , Japan
Tel
0787964500
kyomu@phoenix.kobe-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 02 | Month | 26 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2026 | Year | 01 | Month | 15 | Day |
Date of IRB
| 2026 | Year | 01 | Month | 15 | Day |
Anticipated trial start date
| 2026 | Year | 02 | Month | 17 | Day |
Last follow-up date
| 2026 | Year | 10 | Month | 31 | Day |
Date of closure to data entry
| 2028 | Year | 03 | Month | 31 | Day |
Date trial data considered complete
Date analysis concluded
Other
Other related information
This study is conducted as an observational study without intervention. Participants will undergo a one-time assessment including questionnaires and cognitive function tests. Collected data will be anonymized and analyzed.
Management information
Registered date
| 2026 | Year | 02 | Month | 25 | Day |
Last modified on
| 2026 | Year | 02 | Month | 25 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000069501
